Spliceosomal vulnerability of MYCN-amplified neuroblastoma is contingent on PRMT5-mediated regulation of epitranscriptomic and metabolomic pathwaysJodie Bojko(University of Bristol), Karim Malik(University of Bristol)Cancer LettersSeptember 23, 202410.1016/j.canlet.2024.217263Cited by 5SaveCiteExport RISWatch citationsRelated PapersLGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma|Oncotarget|2015|81The small molecule inhibitor YK-4-279 disrupts mitotic progression of neuroblastoma cells, overcomes drug resistance and synergizes with inhibitors of mitosis|Cancer Letters|2017|40